C

Candel Therapeutics
D

CADL

4.95000
USD
0.33
(7.14%)
Market Closed
Volume
15,398
EPS
-2
Div Yield
-
P/E
-3
Market Cap
160,753,908
News

Title: Candel Therapeutics

Sector: Healthcare
Industry: Biotechnology
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.